Ptc Therapeutics (PTCT) Other Operating Expenses (2012 - 2026)

Ptc Therapeutics' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $31.8 million for Q2 2026.

• In Q2 2026, Other Operating Expenses changed N/A year-over-year to $31.8 million; the TTM figure through Jun 2026 stood at $72.3 million (up 603.63% YoY), while the FY2025 annual figure was $800000.0, down 82.12% from the prior year.
• Other Operating Expenses for Q2 2026 stood at $31.8 million, down from $40.5 million in the prior quarter.
• The five-year high for Other Operating Expenses was $128.9 million in Q2 2023, with the low at -$6.3 million in Q4 2022.
• The 5-year median for Other Operating Expenses is $2.7 million (2023), against an average of $15.4 million.
• Peak annual rise in Other Operating Expenses reached 11800.0% in 2022, while the deepest fall reached 152.07% in 2022.
• Ptc Therapeutics' Other Operating Expenses stood at -$6.3 million in 2022, then surged by 142.86% to $2.7 million in 2023, then jumped by 276.85% to $10.2 million in 2024, then sank by 92.14% to $800000.0 in 2025, then jumped by 3870.25% to $31.8 million in 2026.
• Business Quant data shows PTCT's Other Operating Expenses at $31.8 million in Q2 2026, $40.5 million in Q1 2026, and $800000.0 in Q1 2025.